Diagnosis of tuberculosis by a visually detectable immunoassay for lipoarabinomannan

E D Chan1, R Reves, J T Belisle

  • 1Division of Pulmonary Sciences and Critical Care Medicine, and Department of Cellular and Structural Biology, University of Colorado Health Sciences Center, and National Jewish Medical and Research Center, Denver, Colorado, USA. chane@njc.org

Insights

A new anti-lipoarabinomannan IgG immunoassay shows promise for diagnosing tuberculosis (TB). This visually detectable test is sensitive and specific, offering a potential screening tool for active TB.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Diagnostic Assays

Background:

  • Current tuberculosis (TB) diagnosis relies on sputum or tissue culture, which is technically challenging and often lacks sensitivity.
  • There is a need for simpler, more accessible diagnostic methods for TB detection.

Purpose of the Study:

  • To evaluate the accuracy of a novel colloidal gold-based serological assay for detecting IgG against mycobacterial lipoarabinomannan (LAM).
  • To determine the sensitivity and specificity of this anti-LAM IgG immunoassay in patients with active pulmonary TB and control groups.

Main Methods:

  • Development of a simplified, visually detectable, colloidal gold-based serological assay.
  • Qualitative detection of IgG antibodies targeting the mycobacterial cell wall component, lipoarabinomannan (LAM).
  • Testing the assay in patients with active pulmonary TB and in control individuals with or without latent TB infection.

Main Results:

  • The assay demonstrated high sensitivity for active TB, ranging from 85% to 93%.
  • All five smear-negative active TB patients tested positive for anti-LAM IgG.
  • Specificity varied: 100% in healthy US adults and rheumatology patients, and 89% in an at-risk population.

Conclusions:

  • The anti-LAM IgG immunoassay is a sensitive and specific diagnostic tool for active TB.
  • This assay has the potential to serve as a valuable screening test for active tuberculosis.
  • The test offers a simplified, visually detectable alternative to traditional diagnostic methods.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...